ArticleMolecular therapy. Methods & clinical development2025

Intracranial AAV administration dose-dependently recruits B cells to inhibit the AAV redosing.

Yuge Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.